Sugi Predict

Sugi Predict / Compounds / SCHEMBL4778005

SCHEMBL4778005

SCHEMBL4778005

CC(C)(C)C(=O)CC(=O)C(C)(C)C.CC(C)(C)C(=O)CC(=O)C(C)(C)C.[Cu]

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 1/20 0.34
▸ RCE1 Q9Y256 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HMGCR P04035 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ TBXA2R P21731 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ TSHR P16473 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ VDR P11473 1/20 0.31
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5178638 1.00 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL4837194 0.96 KMT2A (0.39) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL93393 0.96 KMT2A (0.39) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL16712161 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL9566006 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL15788961 0.93 NPC1 (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL9325238 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL21002308 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL21405194 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1
SCHEMBL6910342 0.93 KMT2A (0.37) KMT2AMEN1RCE1HSD11B1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11433368-B2 Method and apparatus of preparing catalyst for fuel cell HYUNDAI MOTOR COMPANY (KR) 2022-09-06 — — US claimed
CN-113398975-B Preparation method of NiCu catalyst for selective hydrogenation of acetylene or butadiene in monoolefin-rich atmosphere, product and application 中国科学技术大学 2022-04-29 — — CN claimed
US-20200190661-A1 Deposition Process Based on Stencil Mask and Application to the Fabrication of Tags Supporting Multi-Functional Traceable Codes 3D OXIDES (FR) 2020-06-18 — — US claimed
CN-111286715-A Method and apparatus for preparing catalyst for fuel cell 现代自动车株式会社 2020-06-16 — — CN claimed
US-20250339848-A1 SO2 TOLERANT CATALYSTS AND METHOD FOR PREPARING SAME GORE & ASS (US) 2025-11-06 — — US disclosed
EP-4526035-A1 <SUP2/>? <SUB2/>?2?SOTOLERANT CATALYSTS AND METHOD FOR PREPARING SAME W. L. Gore & Associates, Inc. (US) 2025-03-26 — — EP disclosed
US-12027711-B2 Thin-film catalyst with enhanced catalyst-support interactions UCHICAGO ARGONNE, LLC (US) 2024-07-02 — — US disclosed
US-20240116044-A1 MANUFACTURING METHOD OF PLATINUM-BASED ALLOY CATALYST USING FLUIDIZED ATOMIC LAYER DEPOSITION KIA CORPORATION (KR) 2024-04-11 — — US disclosed
US-20240109881-A1 Heteroaryl Compounds as Ligand Directed Degraders of IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-04-04 — — US disclosed
WO-2024029508-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL 三井化学株式会社 2024-02-08 — — WO disclosed
WO-2024029507-A1 CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED ARTICLE, AND DENTAL MATERIAL 三井化学株式会社 2024-02-08 — — WO disclosed
WO-2023224939-A1 SO2 TOLERANT CATALYSTS AND METHOD FOR PREPARING SAME W. L. GORE & ASSOCIATES, INC. (US) 2023-11-23 — — WO disclosed
CN-110813343-A Preparation method of doped graphite-like carbon nitride material 上海交通大学 2020-02-21 — — CN disclosed
US-20190109330-A1 THIN-FILM CATALYST WITH ENHANCED CATALYST-SUPPORT INTERACTIONS UCHICAGO ARGONNE, LLC (US) 2019-04-11 — — US disclosed
US-10044045-B2 Process for producing a fuel cell electrode catalyst, fuel cell electrode catalyst and use thereof SHOWA DENKO K.K. (JP) 2018-08-07 — — US disclosed
US-20150093681-A1 METHOD FOR PRODUCING FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST, AND USES THEREOF SHOWA DENKO K.K. (JP) 2015-04-02 — — US disclosed
US-20140170528-A1 PROCESS FOR PRODUCING A FUEL CELL ELECTRODE CATALYST, FUEL CELL ELECTRODE CATALYST AND USE THEREOF SHOWA DENKO K.K. (JP) 2014-06-19 — — US disclosed
EP-2744024-A1 METHOD FOR PRODUCING ELECTRODE CATALYST FOR FUEL CELLS, ELECTRODE CATALYST FOR FUEL CELLS, AND USE OF SAME Showa Denko K.K. (JP) 2014-06-18 — — EP disclosed
US-20080124924-A1 Scheme for copper filling in vias and trenches APPLIED MATERIALS, INC. 2008-05-29 — — US disclosed
WO-2008011403-A2 NEW SCHEME FOR COPPER FILLING IN VIAS AND TRENCHES APPLIED MATERIALS, INC. (US) 2008-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109881-A1 Heteroaryl Compounds as Ligand Directed Degraders of IRAK4 IRAK4, IRAK2, IRAK3 KMT2A 199/4885MEN1 3137/4885RCE1 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.